MedPath

ong term follow-up observational study after clinical trials of AMG531 (Romiplostim) in patients with untreated Aplastic Anemia (531-005 Study)

Not Applicable
Recruiting
Conditions
aplastic anemia
Registration Number
JPRN-UMIN000044014
Lead Sponsor
Kyowa Kirin Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
45
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who are judged by the investigator or sub-investigator to be unfavorable for participation in this research

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath